William Hartzel - 11 Jul 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: SVP, Bioservices
Signature: /s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol: EBS
Transactions as of: 11 Jul 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Jul 2024, 16:33:23 UTC
Previous filing: 11 Jun 2024
Next filing: 13 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+15,000	+45%	$0.000000	48,107	11 Jul 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted under the company's Amended and Restated Stock Incentive Plan. These restricted stock units vest in one installment on the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

Content

Consists of restricted stock units granted under the company's Amended and Restated Stock Incentive Plan. These restricted stock units vest in one installment on the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.